Liquid biopsy is a revolutionary molecular diagnostic tool that allows scientists to detect genetic abnormalities or monitor disease progression non-invasively. However, clinicians encounter several challenges when processing and analyzing blood samples, such as inconsistencies in the plasma yield and pipetting errors in the biomarker detection protocol. Automation can improve liquid biopsy workflows.
Download this white paper from Tecan to learn about
- The key stages required to implement liquid biopsy assays in the clinic
- How to decide which workflow steps to automate
- How to improve plasma isolation using automated phase separation technology
